Plasminogen Activator Inhibitor 1
"Plasminogen Activator Inhibitor 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.
Descriptor ID |
D017395
|
MeSH Number(s) |
D12.644.861.695.500 D12.776.124.125.640 D12.776.872.695.500 D23.119.832.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Plasminogen Activator Inhibitor 1".
Below are MeSH descriptors whose meaning is more specific than "Plasminogen Activator Inhibitor 1".
This graph shows the total number of publications written about "Plasminogen Activator Inhibitor 1" by people in this website by year, and whether "Plasminogen Activator Inhibitor 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2005 | 1 | 1 | 2 |
2006 | 0 | 3 | 3 |
2007 | 2 | 0 | 2 |
2008 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2012 | 0 | 2 | 2 |
2013 | 1 | 1 | 2 |
2014 | 1 | 1 | 2 |
2016 | 2 | 1 | 3 |
2019 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
2021 | 1 | 1 | 2 |
2022 | 2 | 1 | 3 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plasminogen Activator Inhibitor 1" by people in Profiles.
-
Pravastatin Protects Cytotrophoblasts from Hyperglycemia-Induced Preeclampsia Phenotype. Cells. 2024 09 13; 13(18).
-
Deep mutational scanning and massively parallel kinetics of plasminogen activator inhibitor-1 functional stability to probe its latency transition. J Biol Chem. 2022 12; 298(12):102608.
-
Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis. Sci Rep. 2022 09 27; 12(1):16137.
-
Arterial thrombosis in a newborn with homozygous plasminogen activator inhibitor-1 4G/4G polymorphism. Pediatr Blood Cancer. 2022 08; 69(8):e29586.
-
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape. Sci Rep. 2021 09 22; 11(1):18827.
-
Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging. Genome Biol. 2021 06 29; 22(1):194.
-
miR-18a Inhibits BMP4 and HIF-1a Normalizing Brain Arteriovenous Malformations. Circ Res. 2020 10 09; 127(9):e210-e231.
-
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model. J Transl Med. 2020 02 05; 18(1):57.
-
TP53/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer. Aging (Albany NY). 2020 01 27; 12(3):2777-2797.
-
Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis. Blood. 2019 12 26; 134(26):2399-2413.